• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND CO. BD POSIFLUSH XS PRE-FILLED FLUSH SYRINGE NACL 0.9%; SALINE VASCULAR ACCESS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND CO. BD POSIFLUSH XS PRE-FILLED FLUSH SYRINGE NACL 0.9%; SALINE VASCULAR ACCESS FLUSH Back to Search Results
Catalog Number 306572
Device Problem Packaging Problem (3007)
Patient Problem No Patient Involvement (2645)
Event Date 07/09/2020
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that the bd posiflush¿ xs pre-filled flush syringe nacl 0.9% packaging was found damaged before use.The following information was provided by the initial reporter: "the customer experienced error with the posiflush xs 10 ml in april, when a field notice was sent out regarding a damage on the packaging.The same customer experienced the same error now with posiflush xs 10 ml ( but with a different lot-nr 0076414) which is not on the field notice).She describes an error/damage with the packaging.The customer had 5 boxes (with same lot) with 30 syringes each box, and discovered errors with all products.".
 
Manufacturer Narrative
H.6.Investigation summary a device history record review was performed for provided lot number 0076414 and the review did not reveal any detected quality issues during the production process that could have contributed to this reported incident.As samples were unavailable for return, our quality team could not complete a thorough sample investigation.Recently, a field safety notice was communicated related to this potential defect; however, the lot number reported for this incident is not a part of the notice and was manufactured on a separate production line.Our quality team will continue to closely monitor the production process for signs of this potential defect.See h.10.
 
Event Description
It was reported that the bd posiflush¿ xs pre-filled flush syringe nacl 0.9% packaging was found damaged before use.The following information was provided by the initial reporter: "the customer experienced error with the posiflush xs 10 ml in april, when a field notice was sent out regarding a damage on the packaging.The same customer experienced the same error now with posiflush xs 10 ml ( but with a different lot-nr 0076414) which is not on the field notice).She describes an error/damage with the packaging.The customer had 5 boxes (with same lot) with 30 syringes each box, and discovered errors with all products.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD POSIFLUSH XS PRE-FILLED FLUSH SYRINGE NACL 0.9%
Type of Device
SALINE VASCULAR ACCESS FLUSH
Manufacturer (Section D)
BECTON, DICKINSON AND CO.
donore road
drogheda
MDR Report Key10347676
MDR Text Key202962091
Report Number9616657-2020-00115
Device Sequence Number1
Product Code NGT
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 08/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/30/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date02/28/2023
Device Catalogue Number306572
Device Lot Number0076414
Was Device Available for Evaluation? No
Date Manufacturer Received07/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-